{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:03:25Z","timestamp":1784257405258,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R24 AI067039"],"award-info":[{"award-number":["R24 AI067039"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30 AI027757"],"award-info":[{"award-number":["P30 AI027757"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30 AI027767"],"award-info":[{"award-number":["P30 AI027767"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA047045"],"award-info":[{"award-number":["R01DA047045"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA058938"],"award-info":[{"award-number":["R01DA058938"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U24DA058307"],"award-info":[{"award-number":["U24DA058307"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10461-025-04877-7","type":"journal-article","created":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T23:44:45Z","timestamp":1759103085000},"page":"418-428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differences in Methamphetamine Use, Self-Reported Impact, and HIV-Related Outcomes by Gender and Sexual Orientation in a Multisite U.S. Cohort of People with HIV in Care"],"prefix":"10.1007","volume":"30","author":[{"given":"R.J.","family":"Fredericksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Nance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.N.","family":"Drumright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.S.","family":"Mixson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Ruderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.M.","family":"Whitney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.H.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Saag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Eron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Napravnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bamford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cachay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"Yendewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Keruly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Safren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.C.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.W.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"12","key":"4877_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/jamapsychiatry.2021.2588","volume":"78","author":"B Han","year":"2021","unstructured":"Han B, et al. Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults. JAMA Psychiatry. 2021;78(12):1329\u201342.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"4877_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nyas.14688","volume":"1508","author":"CM Jones","year":"2022","unstructured":"Jones CM, et al. Methamphetamine use in the united states: epidemiological update and implications for prevention, treatment, and harm reduction. Ann N Y Acad Sci. 2022;1508(1):3\u201322.","journal-title":"Ann N Y Acad Sci"},{"key":"4877_CR3","doi-asserted-by":"publisher","first-page":"104674","DOI":"10.1016\/j.neubiorev.2022.104674","volume":"137","author":"AP Daiwile","year":"2022","unstructured":"Daiwile AP, Jayanthi S, Cadet JL. Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: potential therapeutic impacts. Neurosci Biobehav Rev. 2022;137:104674.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"4877_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/ajad.13501","volume":"33","author":"RK McHugh","year":"2024","unstructured":"McHugh RK, et al. Gender differences in the prevalence of stimulant misuse in the united states: 2015\u20132019. Am J Addict. 2024;33(3):283\u20139.","journal-title":"Am J Addict"},{"issue":"1","key":"4877_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S1550-8579(08)80005-8","volume":"5","author":"DE Dluzen","year":"2008","unstructured":"Dluzen DE, Liu B. Gender differences in methamphetamine use and responses: a review. Gend Med. 2008;5(1):24\u201335.","journal-title":"Gend Med"},{"key":"4877_CR6","doi-asserted-by":"publisher","first-page":"107539","DOI":"10.1016\/j.addbeh.2022.107539","volume":"137","author":"MM Philbin","year":"2023","unstructured":"Philbin MM, et al. Age-related patterns of cocaine and methamphetamine use across the life course in the united states: disparities by gender and sexual identity among adults. Addict Behav. 2023;137:107539.","journal-title":"Addict Behav"},{"key":"4877_CR7","unstructured":"Substance Abuse and Mental Health Services Administration. National survey on drug use and health: results from the 2018 US department of health and human services, substance abuse and mental health services administration, National survey on drug use and health. Rockville, MD; 2019."},{"issue":"4","key":"4877_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/02791072.2016.1213470","volume":"48","author":"JL Simpson","year":"2016","unstructured":"Simpson JL, et al. Psychological burden and gender differences in Methamphetamine-Dependent individuals in treatment. J Psychoact Drugs. 2016;48(4):261\u20139.","journal-title":"J Psychoact Drugs"},{"issue":"6","key":"4877_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1360-0443.2004.00707.x","volume":"99","author":"RA Rawson","year":"2004","unstructured":"Rawson RA, et al. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004;99(6):708\u201317.","journal-title":"Addiction"},{"issue":"3","key":"4877_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1148\/radiol.2015142541","volume":"277","author":"MF Regner","year":"2015","unstructured":"Regner MF, et al. Sex differences in Gray matter changes and Brain-Behavior relationships in patients with stimulant dependence. Radiology. 2015;277(3):801\u201312.","journal-title":"Radiology"},{"issue":"1","key":"4877_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0306-4603(03)00082-0","volume":"29","author":"ML Brecht","year":"2004","unstructured":"Brecht ML, et al. Methamphetamine use behaviors and gender differences. Addict Behav. 2004;29(1):89\u2013106.","journal-title":"Addict Behav"},{"issue":"1","key":"4877_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jsat.2004.10.009","volume":"28","author":"YI Hser","year":"2005","unstructured":"Hser YI, Evans E, Huang YC. Treatment outcomes among women and men methamphetamine abusers in California. J Subst Abuse Treat. 2005;28(1):77\u201385.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"4877_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/ADT.0b013e3182213ef1","volume":"11","author":"DL Polcin","year":"2012","unstructured":"Polcin DL, et al. Gender differences in psychiatric symptoms among methamphetamine dependent residents in sober living houses. Addict Disord their Treat. 2012;11(2):53\u201363.","journal-title":"Addict Disord their Treat"},{"key":"4877_CR14","unstructured":"National Institute on Drug Abuse. Substance abuse in women research report: sex and gender differences in substance use. 2020 March 26, 2021]; Available from: https:\/\/www.drugabuse.gov\/publications\/research-reports\/substance-use-in-women\/sex-gender-differences-in-substance-use"},{"key":"4877_CR15","unstructured":"National Institute on Drug Abuse. Methamphetamine research report: are people who misuse methamphetamine at risk for contracting HIV\/AIDS and hepatitis B and C?. 2019 May 5, 2024]; Available from: https:\/\/nida.nih.gov\/publications\/research-reports\/methamphetamine\/are-people-who-misuse-methamphetamine-risk-contracting-hivaids-hepatitis-b-c"},{"issue":"3","key":"4877_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11481-015-9604-2","volume":"10","author":"RC Passaro","year":"2015","unstructured":"Passaro RC, et al. The complex interaction between methamphetamine abuse and HIV-1 pathogenesis. J Neuroimmune Pharmacol. 2015;10(3):477\u201386.","journal-title":"J Neuroimmune Pharmacol"},{"key":"4877_CR17","doi-asserted-by":"publisher","first-page":"109649","DOI":"10.1016\/j.drugalcdep.2022.109649","volume":"240","author":"HM Crane","year":"2022","unstructured":"Crane HM, et al. Associations between drug and alcohol use, smoking, and frailty among people with HIV across the united States in the current era of antiretroviral treatment. Drug Alcohol Depend. 2022;240:109649.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"4877_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11481-016-9699-0","volume":"11","author":"V Soontornniyomkij","year":"2016","unstructured":"Soontornniyomkij V, et al. Effects of HIV and methamphetamine on brain and behavior: evidence from human studies and animal models. J Neuroimmune Pharmacol. 2016;11(3):495\u2013510.","journal-title":"J Neuroimmune Pharmacol"},{"key":"4877_CR19","unstructured":"Centers for AIDS Research Network of Integrated Clinical Systems. 2021 April 17. 2019]; Available from: https:\/\/www.uab.edu\/cnics\/"},{"key":"4877_CR20","doi-asserted-by":"crossref","unstructured":"Fredericksen RJ et al. Integrating a web-based patient assessment into primary care for HIV-infected adults. J AIDS HIV Res, 2012. 4(1).","DOI":"10.5897\/JAHR11.046"},{"issue":"3","key":"4877_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/09595230500170266","volume":"24","author":"DA Newcombe","year":"2005","unstructured":"Newcombe DA, Humeniuk RE, Ali R. Validation of the world health organization alcohol, smoking and substance involvement screening test (ASSIST): report of results from the Australian site. Drug Alcohol Rev. 2005;24(3):217\u201326.","journal-title":"Drug Alcohol Rev"},{"issue":"16","key":"4877_CR22","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","volume":"158","author":"K Bush","year":"1998","unstructured":"Bush K, et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol use disorders identification test. Arch Intern Med. 1998;158(16):1789\u201395.","journal-title":"Arch Intern Med"},{"issue":"9","key":"4877_CR23","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1161\/01.STR.0000027209.59821.98","volume":"33","author":"S Kiechl","year":"2002","unstructured":"Kiechl S, et al. Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Stroke. 2002;33(9):2170\u20136.","journal-title":"Stroke"},{"issue":"1","key":"4877_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/ADM.0000000000000172","volume":"10","author":"KL Cropsey","year":"2016","unstructured":"Cropsey KL, et al. Cigarette smokers are less likely to have undetectable viral loads: results from four HIV clinics. J Addict Med. 2016;10(1):13\u20139.","journal-title":"J Addict Med"},{"key":"4877_CR25","volume-title":"E-cigarette use among persons living with HIV, in International AIDS society meeting","author":"R Nance","year":"2017","unstructured":"Nance R, Fredericksen DJ, Cropsey R, Chander K, Mugavero G, Christopoulos M, Geng K, Mathews E, Hahn W, Mayer A, O\u2019Cleirigh K, Eron C, Saag J, Kitahata M, Crene M. H., E-cigarette use among persons living with HIV., in International AIDS Society Meeting. France: Paris; 2017."},{"issue":"3","key":"4877_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10461-006-9078-6","volume":"10","author":"JM Simoni","year":"2006","unstructured":"Simoni JM, et al. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227\u201345.","journal-title":"AIDS Behav"},{"key":"4877_CR27","doi-asserted-by":"publisher","first-page":"106544","DOI":"10.1016\/j.addbeh.2020.106544","volume":"111","author":"D Connolly","year":"2020","unstructured":"Connolly D, Gilchrist G. Prevalence and correlates of substance use among transgender adults: A systematic review. Addict Behav. 2020;111:106544.","journal-title":"Addict Behav"},{"key":"4877_CR28","doi-asserted-by":"crossref","unstructured":"Cotaina M et al. Substance use in the transgender population: A Meta-Analysis. Brain Sci, 2022. 12(3).","DOI":"10.3390\/brainsci12030366"},{"issue":"2","key":"4877_CR29","doi-asserted-by":"publisher","first-page":"e2036512","DOI":"10.1001\/jamanetworkopen.2020.36512","volume":"4","author":"JMW Hughto","year":"2021","unstructured":"Hughto JMW, et al. Prevalence and Co-occurrence of alcohol, nicotine, and other substance use disorder diagnoses among US transgender and cisgender adults. JAMA Netw Open. 2021;4(2):e2036512.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"4877_CR30","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/ADM.0000000000000769","volume":"15","author":"MC Frost","year":"2021","unstructured":"Frost MC, et al. Disparities in documented drug use disorders between transgender and cisgender U.S. Veterans health administration patients. J Addict Med. 2021;15(4):334\u201340.","journal-title":"J Addict Med"},{"issue":"3","key":"4877_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1089\/lgbt.2021.0192","volume":"10","author":"GN Baguso","year":"2023","unstructured":"Baguso GN, et al. Mental distress and use of stimulants: analysis of a longitudinal cohort of transgender women. LGBT Health. 2023;10(3):228\u201336.","journal-title":"LGBT Health"},{"issue":"4","key":"4877_CR32","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1089\/lgbt.2015.0001","volume":"2","author":"SL Reisner","year":"2015","unstructured":"Reisner SL, et al. Substance use to Cope with stigma in healthcare among U.S. Female-to-Male trans masculine adults. LGBT Health. 2015;2(4):324\u201332.","journal-title":"LGBT Health"},{"key":"4877_CR33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.socscimed.2015.11.010","volume":"147","author":"JM White Hughto","year":"2015","unstructured":"White Hughto JM, Reisner SL, Pachankis JE. Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222\u201331.","journal-title":"Soc Sci Med"},{"issue":"1","key":"4877_CR34","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1186\/s12879-022-07868-4","volume":"22","author":"E Hsiang","year":"2022","unstructured":"Hsiang E, et al. Prevalence and correlates of substance use and associations with HIV-related outcomes among trans women in the San Francisco Bay area. BMC Infect Dis. 2022;22(1):886.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"4877_CR35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1080\/15332640.2016.1264338","volume":"17","author":"S Matsuzaka","year":"2018","unstructured":"Matsuzaka S. Transgressing gender norms in addiction treatment: transgender rights to access within gender-segregated facilities. J Ethn Subst Abuse. 2018;17(4):420\u201333.","journal-title":"J Ethn Subst Abuse"},{"issue":"1","key":"4877_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12160-013-9565-8","volume":"47","author":"JM Sevelius","year":"2014","unstructured":"Sevelius JM, et al. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5\u201316.","journal-title":"Ann Behav Med"},{"issue":"2","key":"4877_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1300\/J463v03n02_05","volume":"3","author":"E Lombardi","year":"2007","unstructured":"Lombardi E. Substance use treatment experiences of transgender\/transsexual men and women. J LGBT Health Res. 2007;3(2):37\u201347.","journal-title":"J LGBT Health Res"},{"key":"4877_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13011-015-0015-4","volume":"10","author":"T Lyons","year":"2015","unstructured":"Lyons T, et al. A qualitative study of transgender individuals\u2019 experiences in residential addiction treatment settings: stigma and inclusivity. Subst Abuse Treat Prev Policy. 2015;10:17.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"4877_CR39","unstructured":"Substance use in women research report: sex and gender differences in substance abuse.. 2020, National Institute on Drug Abuse."},{"issue":"2","key":"4877_CR40","first-page":"155","volume":"19","author":"L Orza","year":"2017","unstructured":"Orza L, et al. In women\u2019s eyes: key barriers to women\u2019s access to HIV treatment and a Rights-Based approach to their sustained Well-Being. Health Hum Rights. 2017;19(2):155\u201368.","journal-title":"Health Hum Rights"},{"issue":"8","key":"4877_CR41","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s10461-011-0127-4","volume":"16","author":"EL Machtinger","year":"2012","unstructured":"Machtinger EL, et al. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav. 2012;16(8):2091\u2013100.","journal-title":"AIDS Behav"},{"issue":"1","key":"4877_CR42","doi-asserted-by":"publisher","first-page":"10709","DOI":"10.1038\/s41598-023-37948-7","volume":"13","author":"E Gruszczynska","year":"2023","unstructured":"Gruszczynska E, Rzeszutek M. HIV\/AIDS stigma accumulation among people living with HIV: a role of general and relative minority status. Sci Rep. 2023;13(1):10709.","journal-title":"Sci Rep"},{"key":"4877_CR43","first-page":"1293","volume-title":"HIV stigma and health care discrimination experienced by Hispanic or Latino persons with HIV \u2014 United states, 2018\u20132020, in Morbidity and mortality weekly report","author":"M Padilla","year":"2022","unstructured":"Padilla M, Patel D, Beer L, Tie Y, Nair P, Salabarria-Pena Y, Henny KD, Thomas D, Dasgupta S. HIV stigma and health care discrimination experienced by Hispanic or Latino persons with HIV \u2014 United states, 2018\u20132020, in Morbidity and mortality weekly report. Editor: C.f.D. Control; 2022. pp. 1293\u2013300."},{"issue":"1","key":"4877_CR44","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12889-022-12778-w","volume":"22","author":"AM Stanton","year":"2022","unstructured":"Stanton AM, et al. It\u2019s how we get to know each other: substance use, connectedness, and sexual activity among men who have sex with men who are living with HIV. BMC Public Health. 2022;22(1):425.","journal-title":"BMC Public Health"},{"key":"4877_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/1874120701004010141","volume":"4","author":"BJ Dew","year":"2010","unstructured":"Dew BJ. Toward a better Understanding of Non-Addicted, Methamphetamine-Using, men who have sex with men (MSM) in Atlanta. Open AIDS J. 2010;4:141\u20137.","journal-title":"Open AIDS J"},{"issue":"3","key":"4877_CR46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0740-5472(02)00223-4","volume":"22","author":"SJ Semple","year":"2002","unstructured":"Semple SJ, Patterson TL, Grant I. Motivations associated with methamphetamine use among HIV\u2009+\u2009men who have sex with men. J Subst Abuse Treat. 2002;22(3):149\u201356.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"4877_CR47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12954-024-00986-z","volume":"21","author":"RJ Fredericksen","year":"2024","unstructured":"Fredericksen RJ, et al. Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural united states: a multi-site qualitative inquiry. Harm Reduct J. 2024;21(1):74.","journal-title":"Harm Reduct J"},{"key":"4877_CR48","doi-asserted-by":"crossref","unstructured":"Carbone-Lopez K, Gatweood-Owens J, Miller J. Women\u2019s \u2018storylines\u2019 of methamphetamine iniitiation in the Midwest. J Drug Issues, 2012. 42(3).","DOI":"10.1177\/0022042612456013"},{"issue":"13","key":"4877_CR49","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1097\/QAD.0000000000002680","volume":"34","author":"J Feelemyer","year":"2020","unstructured":"Feelemyer J, et al. Associations between methamphetamine use and lack of viral suppression among a cohort of HIV-positive persons who inject drugs in Hai phong, Vietnam. AIDS. 2020;34(13):1875\u201382.","journal-title":"AIDS"},{"issue":"1","key":"4877_CR50","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.1038\/s41598-020-64069-2","volume":"10","author":"HH Lai","year":"2020","unstructured":"Lai HH, et al. Methamphetamine use associated with Non-adherence to antiretroviral treatment in men who have sex with men. Sci Rep. 2020;10(1):7131.","journal-title":"Sci Rep"},{"key":"4877_CR51","doi-asserted-by":"crossref","unstructured":"Khalili M, Sadeghirad B, Bach P, Crabtree A, Javadi S, Sadeghi E, Moradi S, Fashami FM, Nakhaeizadeh M, Salehi S, Sofi-Mahmudi A, Nasiri N, Mehmandoost S, Moallef S, Langeroodi SMF, Moe J, Lysyshyn M, et al. Management of amphetamine and methamphetamine use disorders: a systematic review and network meta-analysis of randomized trials. International Journal of Mental Health and Addiction; 2024.","DOI":"10.1007\/s11469-024-01379-w"},{"issue":"11","key":"4877_CR52","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1007\/s10461-017-1718-5","volume":"21","author":"HM Crane","year":"2017","unstructured":"Crane HM, et al. HIV provider Documentation and actions following patient reports of at-risk behaviors and conditions when identified by a web-based point-of-care assessment. AIDS Behav. 2017;21(11):3111\u201321.","journal-title":"AIDS Behav"},{"key":"4877_CR53","unstructured":"Fredericksen RJ, Crane HM, Lober W, Fitzsimmons E, Short D. PROgress evidence review and summary: impact of administering patient-reported measures and outcomes (PROs) within HIV routine care. 2020."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04877-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04877-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04877-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:06:33Z","timestamp":1771945593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04877-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4877"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04877-7","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"31 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"E. Cachay has received unrestricted research grants paid to the University of California Reagents from Gilead Sciences for unrelated hepatitis C virus research projects and has received payment honoraria from Gilead Science (symposium, educational event November 2021) and THERATechnologies (advisory board consulting fees for an unrelated topic in 2022). K. Christopoulos has been a medical advisory board member for Gilead and a workshop participant for Janssen. J. Eron declares research funding from Gilead Sciences and ViiV Healthcare University of North Carolina-Chapel Hill as an investigator, and consulting fees paid to him from Merck & Co, ViiV Healthcare and Gilead Sciences. All other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}